Evidence & regulatory context
- Mechanism
- Bletilla striata polysaccharide hydrogel; botanical macromolecule biomaterial.
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseWoundKunmingMalen = Two groups with 20 mice per group; one third of the mice in…Topical, applied to cover the wound areaBSP hydrogel formed from a 40 mg/mL BSP aqueous solution; s…Applied after wound creation, from the day of wounding
Model: Full-thickness excisional dorsal skin wound created with an 8 mm biopsy punch under 2% pentobarbital anaesthesia (45 mg/kg, intraperitoneal)
BSP at 5 and 10 ug/mL slightly promoted L929 fibroblast growth with no cytotoxicity up to 100 ug/mL and enhanced scratch closure by 48 h. In vivo the BSP hydrogel reduced unhealed wound area at days 3 and 6 versus untreated control and was the only group to achieve wound closure within 12 days. Tre…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.